Kucera Miroslav, Barna Milos, Horácek Ondrej, Kováriková Jaroslava, Kucera Alexander
Department for Sports Medicine and Rehabilitation, 2nd Medical Faculty of the Charles University Prague, Prague.
Wien Med Wochenschr. 2004 Nov;154(21-22):498-507. doi: 10.1007/s10354-004-0114-8.
In a controlled, double blind, randomized multicentre study, the efficacy and safety of the topical comfrey product Traumaplant (10% active ingredient of a 2.5:1 aqueous ethanolic pressed juice of freshly harvested, cultivated comfrey herb (Symphytum x uplandicum NYMAN), corresponding to 25 g of fresh herb per 100 g of cream; n = 104) was tested against a 1% product (corresponding to 2.5 g of fresh comfrey herb in 100 g of cream; n = 99) in 203 patients with acute ankle distortion. With the high concentration, decrease of the scores for pain on active motion, pain at rest and functional impairment was highly significant and clinically relevant on days T3-4 as well as T7 (p < 0.001). Amelioration of swellings as compared to reference was also significant on day 3-4 (p < 0.01). Efficacy was judged good to excellent in 85.6% of cases with verum and in 65.7% of cases with reference on day 3-4. Overall tolerability was excellent.
在一项对照、双盲、随机多中心研究中,针对203例急性踝关节扭伤患者,对局部用紫草产品Traumaplant(10%活性成分,来自新鲜收获、种植的紫草(Symphytum x uplandicum NYMAN)按2.5:1比例制成的水乙醇压榨汁,相当于每100克乳膏含25克新鲜草药;n = 104)与1%产品(相当于100克乳膏含2.5克新鲜紫草草药;n = 99)的疗效和安全性进行了测试。使用高浓度产品时,在T3 - 4天以及T7天时,主动活动时疼痛评分、静息痛评分和功能障碍评分的降低具有高度显著性且具有临床相关性(p < 0.001)。与对照相比,在第3 - 4天时肿胀的改善也具有显著性(p < 0.01)。在第3 - 4天时,85.6%使用试验产品的病例和65.7%使用对照产品的病例疗效判定为良好至优秀。总体耐受性良好。